(1 - 12 from 13
)
$22 Million Joint Venture To Purse Neurochemical Reset For ...www.worldhealth.net › news › 22-million-joint-venture-purse-neuroc...
www.worldhealth.net
One of those studies included a large on led by DemeRx CEO Deborah Mash, Ph.D; now DemeRx and ATAI are hoping to get regulatory ...
sorted by relevance / date